Goldman Sachs Group Inc Second Sight Medical Products Inc Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 14, 2024	BUY	$1.22 - $2.57 $35,824 - $75,465	29,364 New	29,364 $60,000
Q2 2022 Aug 15, 2022	SELL	$1.22 - $2.57 $7,433 - $15,659	-6,093 Reduced 17.18%	29,364 $60,000
Q1 2022 May 16, 2022	BUY	$1.16 - $1.83 $1,748 - $2,757	1,507 Added 4.44%	35,457 $51,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.41 $15,113 - $31,617	9,272 Added 37.57%	33,950 $55,000
Q3 2021 Nov 10, 2021	BUY	$3.11 - $4.75 $76,748 - $117,220	24,678 New	24,678 $79,000

Ticker EYES
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,136,400
Market Cap $54.4M
Description
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.